| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.28 | 1e-06 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.27 | 2e-06 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.26 | 4e-06 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |